Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here. The US stock market started 2024 optimistically. In the first quarter, the fund returned 8.29% (gross) and 8.09% (net) compared to 11.41% for the Russell 1000 Growth Index and […]

Abbott Laboratories (ABT) Q1 2024 Earnings: Exceeds Analyst Estimates and Raises Full-Year Guidance

https://www.investing.com/news/company-news/citi-maintains-stock-target-on-abbott-labs-with-buy-rating-on-strong-q1-performance-93CH-3385136

Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations and Raising Guidance

We also love that EPS results on Tuesday came in above the range management had forecasted.

Abbott Laboratories'' first-quarter earnings on Wednesday exceeded analyst expectations, but its stock fell after the company gave current-quarter guidance mostly below estimates.

These are the stocks posting the largest moves in midday trading.

Abbott Labs Faces Downturn Post-Q1 Results Amid Mixed Sector Performances

Abbott Laboratories (NYSE:NYSE:ABT) Q1 2024 Results Conference Call April 17, 2024 9:00 AM ETCompany ParticipantsMike Comilla - Vice President, Investor…

Abbott stock see-sawed early Wednesday after the giant health care company reported adjusted income of 98 cents a share on $10 billion in first-quarter sales. The Street projected earnings of 95 cents a share and $9.88 billion in sales, according to FactSet. During the year-earlier period, Abbott Laboratories (ABT) earned $1.03 per share and reported $9.75 billion in sales. For…